CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Sponsor: Cxlusa
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Cxlusa
- Corneal Diseases · Phase PHASE2 · Dec 2020
- Degeneration · Apr 2017
- Degeneration · Feb 2017
- Degeneration · Feb 2017
More terminations from Cxlusa
This PHASE2 trial investigates Keratoconus and is currently terminated or withdrawn. Cxlusa leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Nov 2018 — Jan 2021 [monthly]
Terminated PHASE2
Status: Unknown Status → Terminated · Phase: PHASE4 → PHASE2
-
Jul 2018 — Nov 2018 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cxlusa
For direct contact, visit the study record on ClinicalTrials.gov .